Inogen (INGN) Return on Capital Employed (2014 - 2026)
Inogen (INGN) posted quarterly Return on Capital Employed of 13.81% for Q1 2026, up 50.0% year-over-year from 9.21% in Q1 2025, and down 9.43% quarter-over-quarter from 12.62% in Q4 2025.
Inogen (INGN) Return on Capital Employed (2014 - 2026) Analysis & Trends
Inogen (INGN) has reported Return on Capital Employed for 13 consecutive years, with 13.81% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Capital Employed rose 50.0% year-over-year to 13.81%; the TTM figure through Mar 2026 stood at 13.81% (up 50.0% YoY), while the FY2025 annual figure was 12.92%, up 521.0% from the prior year.
- Return on Capital Employed eased to 13.81% in Q1 2026 per INGN's latest filing, from 12.62% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 0.52% in Q1 2022 and bottomed at 46.51% in Q3 2023.
- Historically, Return on Capital Employed has averaged 22.32% across 5 years, with a median of 18.94% in 2024.
- Annual changes were most pronounced in 2023 — Return on Capital Employed slumped 3824 bps — and 2025, when it soared 2770 bps.
- Inogen's Return on Capital Employed stood at 22.92% in 2022, then tumbled by 82 bps to 41.68% in 2023, then jumped by 55 bps to 18.94% in 2024, then surged by 33 bps to 12.62% in 2025, then dropped by 9 bps to 13.81% in 2026.
- Business Quant data shows INGN's Return on Capital Employed at 13.81% in Q1 2026, 12.62% in Q4 2025, and 13.2% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 12.08% |
| 10 | Inogen | 151.59 Mn | 46.05 Mn | 43.27 Mn | -14.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -14.36% |
| Mar 31, 2026 | -13.81% |
| Dec 31, 2025 | -12.62% |
| Sep 30, 2025 | -13.20% |
| Jun 30, 2025 | -13.56% |
| Mar 31, 2025 | -14.31% |
| Dec 31, 2024 | -18.94% |
| Sep 30, 2024 | -25.56% |
| Jun 30, 2024 | -41.25% |
| Mar 31, 2024 | -42.00% |
| Dec 31, 2023 | -41.68% |
| Sep 30, 2023 | -46.51% |
| Jun 30, 2023 | -31.96% |
| Mar 31, 2023 | -28.19% |
| Dec 31, 2022 | -22.92% |
| Sep 30, 2022 | -8.27% |
| Jun 30, 2022 | -4.06% |
| Mar 31, 2022 | -0.52% |
| Dec 31, 2021 | 2.10% |
| Sep 30, 2021 | 2.33% |